Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-10-26

Clinical Trial Update: Oliceridine in Patients With Acute Burn Injuries [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating oliceridine in patients with acute burn injuries.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oliceridine (Oliceridine)

Snippet

Sponsor: University of Tennessee | Conditions: Acute Pain, Burns | Phase 4 | Status: COMPLETED